01:05 AM EST, 11/09/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We keep our 12-month target of $238, valuing ALL shares at 9.5x our newly initiated 2027 operating EPS estimate of $25.10 and at 10.2x our 2026 EPS estimate of $23.25 (raised $1.00) vs their three-year average forward multiple of 13x and peer average of 14x. We lift our 2025 EPS estimate by $6.92. Q3 EPS of $11.17 vs $3.91 topped our $4.25 EPS estimate and the $7.54 consensus view on dramatically improved underwriting results (evidenced by the Q3 combined ratio of 80.1% vs 96.4%), amid lower catastrophe losses (of $558M versus $1.4B). While encouraging, we caution the Q3 results are not likely a run rate. Underwriting results excluding catastrophes also improved, and the underlying combined ratio was 78.7% vs 83.2%. While pricing may become more competitive after this "light" catastrophe quarter, we view ALL well positioned in the economically defensive personal lines space and view ALL shares (currently trading at 8.5x our 2026 EPS estimate) as undervalued vs peer and historical averages.